Incidence, severity, and prevention of infections in chronic granulomatous disease.
about
X-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase.Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registryFollow up of patients with chronic granulomatous disease diagnosed since 1990Vaccines against invasive Salmonella disease: current status and future directionsPrevention of infections during primary immunodeficiencyChronic granulomatous diseaseCu,Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burstThe p47phox mouse knock-out model of chronic granulomatous diseaseEarly interferon-γ production in human lymphocyte subsets in response to nontyphoidal Salmonella demonstrates inherent capacity in innate cellsOrofacial findings in chronic granulomatous disease: report of twelve patients and review of the literature.Staphylococcus aureus - antimicrobial resistance and the immunocompromised child.Successful hepatectomy for hepatic abscess with chronic granulomatous disease: a case report.Microarray analysis of response of Salmonella during infection of HLA-B27- transfected human macrophage-like U937 cells.Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in AfricansPeriplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase.Th17 cytokines and the gut mucosal barrierGlucose 6-phosphate dehydrogenase is required for Salmonella typhimurium virulence and resistance to reactive oxygen and nitrogen intermediates.Inflammation and vitamin D: the infection connectionMutations in the promoter region of the gene for gp91-phox in X-linked chronic granulomatous disease with decreased expression of cytochrome b558.Localized reactive oxygen and nitrogen intermediates inhibit escape of Listeria monocytogenes from vacuoles in activated macrophages.Control of redox balance by the stringent response regulatory protein promotes antioxidant defenses of Salmonella.Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections.Gastrointestinal and hepatic manifestations of primary immune deficiency diseases.Hepatic abscess in patients with chronic granulomatous disease.Requirement for Serratia marcescens cytolysin in a murine model of hemorrhagic pneumoniaGermline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease.Genetic regulation of host responses to Salmonella infection in mice.Thioredoxin 1 promotes intracellular replication and virulence of Salmonella enterica serovar Typhimurium.Common severe infections in chronic granulomatous diseaseEvaluation of bacterial survival and phagocyte function with a fluorescence-based microplate assay.DNA repair is more important than catalase for Salmonella virulence in mice.Infections in patients with inherited defects in phagocytic function.The transcriptional regulator SoxS is required for resistance of Salmonella typhimurium to paraquat but not for virulence in micePrognosis of chronic granulomatous disease.Chronic Granulomatous Disease: A Large, Single-center US ExperiencePyruvate kinase deficiency confers susceptibility to Salmonella typhimurium infection in miceSuccessful treatment of fungal osteomyelitis with voriconazole in a patient with chronic granulomatous disease.Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo.Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro.Macrophages in resistance to candidiasis
P2860
Q24538965-B05D9223-A447-4D67-83AE-BCDAB410912FQ24655272-D5168FC6-E6CE-41C4-BBB1-903DBD7585BBQ24681802-604BCF9C-35DE-4438-B81A-0B8B5376826EQ27007088-FE04C6AD-2928-400F-BA3C-A45F93091528Q27008430-CD8387EA-E093-4A79-A8CE-904298247FFEQ27009322-FEB77EA7-1919-4C78-AAE0-0689635D5255Q28487322-6801E41B-CE90-43C1-89BD-8C006C8A7173Q28504676-A5F221DE-8334-4C65-BCDF-CC5006E9C55CQ28748686-44EFB55F-9E6D-45AD-959A-63063A8CE8A7Q33531937-F576A0A8-64BE-4D68-9312-8242357FD907Q33604961-CAB79AA4-5EC6-4701-A64E-2BCCF8CC6839Q33606830-0A77C556-A5E1-45DA-9ED5-B264550F70AAQ33645049-23FC1049-D6F6-4718-BEBD-902AE2B58BF2Q33733849-56B7A93E-3163-40DE-A61C-4637D2EE84F4Q33740986-0E163BC8-0B25-4347-BF9A-E309C817DA10Q33743570-EDF54A43-FE36-4694-A80D-653C51B266A6Q34000092-CE1C253A-D69C-465E-843D-ACA0BA652EBFQ34161811-017F5D83-69CA-49B9-A897-4BD9B17D882CQ34185348-B56D3701-CFE1-4BB0-B169-2DCEC6722C33Q34273258-F5291537-6665-405B-9923-395A5CEACC03Q34299203-0C2E9DE0-898A-4CAC-9906-8C5F26C647C6Q34423996-7B0D43C9-9D00-44B3-81F2-A619C9248E53Q34469023-96C80210-545C-46D5-A1D3-3FA9B702805FQ34554404-3E6111BF-115D-4F36-AF8F-B11B1BB2EDEAQ34955788-4F427B06-B08F-4F20-886A-DE361D72C4F4Q34992223-3100E38C-77D9-4D20-897F-806A2A1FEA85Q34993039-1A218657-9335-4F32-B74F-A37551BC8EB3Q35073689-8FC7965B-DF4B-4E49-A683-EEA77C70EF34Q35451854-DD80CAA8-D0BE-4CFE-8705-BEBD1EED79BEQ35552569-B640B32F-B434-42EC-860D-23036748CCD3Q35552688-D43445E3-09D6-4859-A51C-CCDFCC77A78EQ35558806-9EDD7EE1-CF63-4209-9790-29873C6B85E8Q35561401-8DEDDE1A-DC08-430A-A761-8A78075DBC77Q35624817-1E0B6F05-A738-45F7-8AF6-83AA133996F3Q36057408-98D6ECB6-FC25-481F-A11B-BD9750E44E25Q36229215-CC0B7A18-0153-415A-A3E3-504D5A2CD23EQ36244604-BA6B52FF-153E-43C9-BFA4-1EC2F77C76F9Q36368755-68A0C9FF-FC26-48A8-BA53-0553EADD4A6EQ36368785-EB1BFC87-D806-4126-AE5E-123D62748FFEQ36574240-66DA5D58-1943-45C9-A69D-F6C28E667CD2
P2860
Incidence, severity, and prevention of infections in chronic granulomatous disease.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Incidence, severity, and prevention of infections in chronic granulomatous disease.
@en
Incidence, severity, and prevention of infections in chronic granulomatous disease.
@nl
type
label
Incidence, severity, and prevention of infections in chronic granulomatous disease.
@en
Incidence, severity, and prevention of infections in chronic granulomatous disease.
@nl
prefLabel
Incidence, severity, and prevention of infections in chronic granulomatous disease.
@en
Incidence, severity, and prevention of infections in chronic granulomatous disease.
@nl
P2093
P1476
Incidence, severity, and prevention of infections in chronic granulomatous disease.
@en
P2093
P304
P356
10.1016/S0022-3476(89)80693-6
P407
P433
P577
1989-04-01T00:00:00Z